SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-22-005102
Filing Date
2022-02-14
Accepted
2022-02-14 09:17:19
Documents
1
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 5 form5.html 5  
1 FORM 5 form5.xml 5 2835
  Complete submission text file 0001140361-22-005102.txt   4436
Mailing Address 37000 GRAND RIVER AVE. SUITE 120 FARMINGTON HILLS MI 48335
Business Address 37000 GRAND RIVER AVE. SUITE 120 FARMINGTON HILLS MI 48335 248-681-9815
Ocuphire Pharma, Inc. (Issuer) CIK: 0001228627 (see all company filings)

IRS No.: 113516358 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 37000 GRAND RIVER AVE SUITE 120 FARMINGTON HILLS MI 48335
Business Address
Ainsworth Sean (Reporting) CIK: 0001830296 (see all company filings)

Type: 5 | Act: 34 | File No.: 001-34079 | Film No.: 22626070